Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
We asked 50 pharma leaders, How important is it for pharmaceutical marketers to monitor what their customers are saying on social media?
Highly important 86%

Somewhat important

14%
Not important 0%

Talk to us:
jupton@advanstar.com

Advertise with us:
Dtaylor-higgins@advanstar.com

18 June, 2013
Behind the Pharma Top 50
In this short video, Editor-in-Chief William Looney looks at the winners and losers in this year's Pharm Exec Top 50 Pharma Companies ...Read more
Is It Time for a 'Common Disease Drug Act'?
A new report on orphan drugs poses an intriguing question about drugs that aren't orphans. When the US and the European Union introduced their legislation to promote orphans, it was assumed that the incentives for drugs for common diseases were economically sufficient. But, asks Anthony Raeside, the principal author of the report: "Is this still the case?" ... Read more
England's Latest Innovation Scorecard: A Patchy Picture
A common gripe from those in the pharma industry in England is that even when their products have been found to be cost effective by NICE, uptake in the NHS can be 'low and slow'. The latest innovation scorecard, just released from the Health and Social Care Information Centre on June 11th, 2013, still paints a patchy picture, writes Leela Barham ... Read more
Cost Containment Hits Digital Technology
Twenty (or arguably, fifty) years into the digital age, there is another revolution sweeping through our industry, one that in many ways has been enabled and accelerated by the digital revolution — the long-dreaded healthcare cost control revolution, now moving front and center on the pharma stage. Bill Drummy reports ... Read more
China Report
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders ... Read more
Also in this issue
US FT Healthcare Conference: Society as Stakeholder
EMA Revises Biosimilars Guidelines
FDA Warning to Baxter Healthcare